Anebulo Pharmaceuticals, Inc. 已正式宣布，其计划自愿从纳斯达克证券交易所退市，并同时向美国证券交易委员会（SEC）提交申请，以注销其证券的登记。此举标志着公司资本市场监管策略的重大调整。
Anebulo Pharmaceuticals, Inc. 已正式宣布，其计划自愿从纳斯达克证券交易所退市，并同时向美国证券交易委员会（SEC）提交申请，以注销其证券的登记。此举标志着公司资本市场监管策略的重大调整。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.